William J. Enright's most recent trade in Barinthus Biotherapeutics Plc. - ADR was a trade of 600,000 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Barinthus Biotherapeutics ... | William J. Enright | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 600,000 | 600,000 | - | - | Share Option (Right to Buy) | |
Bullfrog AI Holdings Inc | William J. Enright | Director | 31 Dec 2024 | 15,000 | 15,000 | - | - | Stock options (right to buy) | ||
Barinthus Biotherapeutics ... | William J. Enright | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 443,981 | 443,981 | - | - | Share Option (Right to Buy) | |
Bullfrog AI Holdings Inc | William J. Enright | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2023 | 40,000 | 40,000 | - | - | Stock options (Right to buy) |